Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
New findings support the routine use of deep learning-based risk assessments, as this method can decrease subjectivity, reduce unnecessary imaging and improve diagnostic accuracy.
The COlorectal Cancer detection with AI, or COCA, model is a cost-effective, scalable solution that turns routine CT scans into opportunistic exams that can be used to proactively identify CRC.
Two respected radiology organizations have issued a stark warning on the new recommendations, stating that they risk confusing patients and “may contribute to thousands of additional breast cancer deaths each year.”
After surgical excision, 10.2% of the architectural distortion cases with nonmalignant pathology at biopsy were upgraded to malignant, researchers reported in the American Journal of Roentgenology.
After witnessing a 6-fold increase in early-stage cancer diagnoses and no change in late-stage disease numbers, experts began to question ongoing screening methods.
The sonographer's experience level is "critical" in screening patients at risk of developing hepatocellular carcinoma, doctors reported in the American Journal of Roentgenology.